
CAS 134362-79-1
:RO 0437626
Description:
RO 0437626, with the CAS number 134362-79-1, is a chemical compound that has garnered interest in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure typically includes functional groups that enhance its solubility and bioavailability, making it suitable for drug formulation. In vitro and in vivo studies have been conducted to evaluate its pharmacokinetics, safety profile, and mechanism of action. While specific characteristics such as melting point, solubility, and stability may vary, RO 0437626 is generally characterized by its ability to modulate biological targets with precision, which is crucial for minimizing side effects and maximizing therapeutic benefits. As research continues, further insights into its properties and potential applications are expected to emerge, contributing to the broader field of medicinal chemistry.
Formula:C27H35N5O4S
Synonyms:- RO 0437626
- N-[(1R)-2-[[(1S,2R,3S)-1-(Cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]amino]-2-oxo-1-(4-thiazolylmethyl)ethyl]-1H-benzimidazole-2-carboxamide
- 1H-Benzimidazole-2-carboxamide, N-[(1R)-2-[[(1S,2R,3S)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]amino]-2-oxo-1-(4-thiazolylmethyl)ethyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Ro 0437626
CAS:P2X1 purinergic receptor antagonistFormula:C27H35N5O4SPurity:98%Color and Shape:SolidMolecular weight:525.66
